✦ LIBER ✦

Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript

✍ Scribed by Tchirkov, A; Couderc, J-L; Périssel, B; Goumy, C; Regnier, A; Uhrhammer, N; Verrelle, P; Berger, M

Book ID: 110056533
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 94 KB
Volume: 20
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2404012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A novel BCR-ABL fusion transcript (e18a2

A novel BCR-ABL fusion transcript (e18a2) in a child with chronic myeloid leukemia

✍ van der Velden, V H J; Beverloo, H B; Hoogeveen, P G; Zwaan, Ch M 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

Molecular response to imatinib in patien

Molecular response to imatinib in patient with Ph negative p190 BCR–ABL transcript positive chronic myeloid leukemia with cyclic leukocytosis

✍ M. Radojkovic; S. Ristic; S. Pavlovic; M. Colovic 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 181 KB

An atypical case of Philadelphia (Ph) negative, e1a2 BCR-ABL transcript positive chronic myeloid leukemia (CML) characterized with cyclic periodic leukocytosis and spontaneous remissions is reported. The patient was treated with imatinib and good hematology response with molecular remission was achi

Identification of a rare e8a2 BCR-ABL fu

Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinib

✍ Cayuela, J M; Rousselot, P; Nicolini, F; Espinouse, D; Ollagnier, C; Bui-Thi, M 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

Imatinib induces a cytogenetic response

Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts

✍ Lee, J-J; Kim, H-J; Kim, Y-J; Lee, S; Hwang, J-Y; Kim, Y-L; Kim, D-W 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 66 KB

Translisin recognition site sequences fl

Translisin recognition site sequences flank translocation breakpoints in a Philadelphia chromosome positive chronic myeloid leukemia patient expressing a novel type of chimeric BCR-ABL transcript (E8-INT-A2)

✍ Mianulli, A; Trabacchi, E; Saglio, G; de Vivo, A; Martinelli, G; Terragna, C; Am 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 84 KB

Isolated thrombocytosis as first sign of

Isolated thrombocytosis as first sign of chronic myeloid leukemia with e6a2 BCR/ABL fusion transcript, JAK2 negativity and complete response to imatinib

✍ Massimo Breccia; Laura Cannella; Daniela Diverio; Paola Streponi; Mauro Nanni; C 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Since very few unusual BCR/ABL fusion transcripts in chronic myeloid leukemia have been reported, no clear evidence exists concerning their clinical and prognostic implications. We describe here a CML case with normal karyotype at standard cytogenetics and an atypical e6a2 BCR/ABL fusion transcript,